Researchers have discovered a molecular switch involved in controlling the transition from normal tissue repair to incomplete, or permanent, damage. The NIH-supported researchers also suggest a possible drug candidate to control this switch and slow the progression of chronic kidney disease. Source: NIH Director’s Blog
